loncastuximab tesirine

Italy

Drugs containing this active substance

  • ZYNLONTA

    Zynlonta is a medicine used to treat adults with a type of cancer called diffuse large B-cell lymphoma (DLBCL), in cases where the cancer has returned after two or more treatments or has not responded to previous therapies.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    loncastuximab tesirine -

    ATC: L01FX22

    Manufacturer: SWEDISH ORPHAN BIOVITRUM AB (PUBL)